Novartis Q1 2024 Earnings. Nvs) q4 2023 earnings conference call january 31, 2024 8:00 am et. Published 2:01 am pst, april 25, 2023.
The swiss pharmaceutical company recorded revenue. Harry kirsch — chief financial officer.
In Q1 2022, Novartis Experienced Solid Growth In Terms Of Sales And Profits.
Wall street projects the maker of zolgensma gene therapy to report $1.53 earnings per share for the quarter, implying ~5% yoy growth, and expects its quarterly.
The Company Reported $1.53 Earnings Per Share For The Quarter, Missing Analysts’ Consensus Estimates Of $1.64 By ($0.11).
Samir shah — global head of investor relations.
Vrna Earnings Date And Information.
Images References :
1,032.75 +14.75 ( 1.45%) Updated :
Verona pharma last announced its quarterly earnings results on february 29th, 2024.
The Company Reported $1.53 Earnings Per Share For The Quarter, Missing Analysts’ Consensus Estimates Of $1.64 By ($0.11).
Nvs) q4 2023 earnings conference call january 31, 2024 8:00 am et.